Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oravexx
- Development stage
- Unknown
- Lead developer
- Orcosa
- Modality
- Small Molecules
- Administration
- Oral, Sublingual
01
Overview
Oravexx is a proprietary, non-addictive cannabidiol (CBD) formulation developed by Orcosa for the management of pain and inflammation. The drug utilizes the Rapid Infusion Technology (RITe) platform, an orally disintegrating tablet designed to dissolve in the mouth in less than three seconds, facilitating rapid absorption of CBD into the bloodstream. Oravexx is currently being evaluated as a non-opioid alternative for treating post-operative pain, such as that following arthroscopic rotator cuff repair, as well as acute and chronic pain conditions including osteoarthritis. By leveraging a fast-acting delivery system, Oravexx aims to provide the therapeutic benefits of CBD with improved bioavailability and onset of action compared to traditional oral formulations.
- Brand names
- Oravexx
- Other names
- cannabidiol
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))CNR1 (Cannabinoid receptor 1)GPR55 (G protein-coupled receptor 55)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on Oravexx.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oravexx.